Link Found Between Anti-Endothelial Cell Antibodies and Thrombosis With Polycythemia Vera
Researchers sought to determine whether there was a link between anti-endothelial cell antibodies and thrombosis in patients with polycythemia vera.
Thrombotic Disorders
No Recurrence of VTE 1 Year after COVID-19-Associated VTE Event
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Avatrombopag Plus MSCs Improved Platelet Recovery After Allo-HSCT
Researchers sought to determine whether avatrombopag with MSCs would improve platelet recovery in patients with prolonged thrombocytopenia after allo-HSCT.
Study Finds Racial Disparities in Cancer-Associated Thrombosis
Researchers sought to determine whether the incidence of CAT was different across designated racial groups.
Deep Vein Thrombosis, Pulmonary Embolism, and Bleeding Risk in COVID-19
Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.
Are Amyloid Fibrin Microclots Central to Long COVID?
Researchers sought to determine the factors that contribute to patients developing clots from Long COVID.
Migraine and Posterior Circulation Ischemic Stroke: Is There a Genetic Overlap?
Researchers sought to assess whether patients with migraine had a greater risk for PCiS than ACiS and if patients genetically predisposed to migraine showed an increased risk for PCiS or ACiS.
Khorana Score Unable to Stratify Patients With Certain Cancer Subtypes by Risk of Venous Thromboembolism
Researchers sought to determine whether the Khorana score would be able to risk-stratify patients according to the 6-month risk of incident VTE.
Fondaparinux Appears More Cost Effective Than Argatroban in Suspected Heparin-Induced Thrombocytopenia
Researchers sought to determine whether fondaparinux would be a more cost-effective treatment compared with argatroban in patients with suspected HIT.
Anticoagulation in Non-ICU Patients With COVID-19 at High Thrombosis Risk
What is the best current strategy for addressing patients with COVID-19 who are at high risk for thrombosis but are not in the ICU?
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...